Author:
Gastambide Francois,Cotel Marie-Caroline,Gilmour Gary,O'Neill Michael J,Robbins Trevor W,Tricklebank Mark D
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference57 articles.
1. Amitai N, Kuczenski R, Behrens MM, Markou A (2011). Repeated phencyclidine administration alters glutamate release and decreases GABA markers in the prefrontal cortex of rats. Neuropharmacology (in press).
2. Ayala JE, Chen Y, Banko JL, Sheffler DJ, Williams R, Telk AN et al (2009). mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning. Neuropsychopharmacology 34: 2057–2071.
3. Barch DM (2010). Pharmacological strategies for enhancing cognition in schizophrenia. Curr Top Behav Neurosci 4: 43–96.
4. Barch DM, Carter CS, Arnsten A, Buchanan RW, Cohen JD, Geyer M et al (2009). Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting. Schizophr Bull 35: 109–114.
5. Barnett JH, Robbins TW, Leeson VC, Sahakian BJ, Joyce EM, Blackwell AD (2010). Assessing cognitive function in clinical trials of schizophrenia. Neurosci Biobehav Rev 34: 1161–1177.